Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Cookies
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Decline Accept
Home › Insider trades › Amphstar Pharmaceuticals, Inc. › CFO exercised or converted 5,053 AMPH derivative securities Insider trades
Why it stands out Derivative exercise or conversion — not an open-market buy.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
All the details
Dates, kept separate
Transaction date Aug 7, 2026
Reporting period Not applicable
Filed with the SEC Aug 11, 2026 CFO Option exercise
Context Classification option exercise
Code M — exercise or conversion of a derivative security
Planned / mechanical clue Footnote references an employee stock purchase plan
Only flagged when a footnote says so; never inferred
Source receipt
Record ID 0001263136-26-000012
Filed / recorded
Aug 11, 2026, 8:57 PM UTC
Added to OQRO Oct 6, 2026, 9:54 PM UTC
Data quality Verified: identifiers matched exactly
Issuer Amphastar Pharmaceuticals, Inc.
Reporting person William J Peters
Relationship Director, Officer
Officer title CFO, EVP & TREASURER
Table Non-derivative (Table I)
Transaction date Aug 7, 2026
Acquired / disposed Acquired (A)
Shares owned after 181,026
Footnotes from the filing Includes 910 shares acquired on May 31, 2026 under the Issuer's 2014 Employee Stock Purchase Plan. The story around this disclosure Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
Jul 9, 2026 Company filing · Form 8-K · Executive change Changed a top executive or board member “On July 9, 2026, the Board of Directors (the “Board”) of Amphastar Pharmaceuticals, Inc. (the “Company”), upon the recommendation of the Nominating and Corporate Governance Committee of the Board (the “Nominating Committee”), approved an increase to the authorized number of directors permitted to serve on the Board from ten (10) to eleven (11) directors and appointed Anthony Pierce, to serve as a Class III director,…” Aug 6, 2026 Company filing · Form 8-K · Results Reported its results Aug 7, 2026 Insider CFO sold ~$184K of AMPH shares in the open market What came next Aug 11, 2026 Insider Director sold ~$162K of AMPH shares in the open market Sep 2, 2026 Insider Officer sold ~$75K of AMPH shares in the open market Sep 16, 2026 Insider Officer sold ~$239K of AMPH shares in the open market Sep 21, 2026 Insider CFO sold ~$103K of AMPH shares in the open market Nov 4, 2026 Insider CFO sold ~$448K of AMPH shares in the open market